drugset / Trial / NCT01316042

Metformin for the Treatment of Premature Pubarche in Girls

NCT01316042 ↗

Terminated 4 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to determine the safety and efficacy of metformin in lowering serum DHEAS levels in girls with premature pubarche and secondary, to observe changes in hormones associated with pubertal development including gonadotropins, sex steroids, insulin, adipocytokines, and growth factors.

Timeline

Start
2011-05
Primary completion
2013-12
Completion
2014-04

Outcome

Outcome not reported

Stopped (Enrollment): “poor recruitment at collaborating sites”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 212.5 mg —

Indications